HolderBook

SANGAMO THERAPEUTICS INC (SGMOQ)

Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.

6
Reporting holders
$86.8K
Reported value
0.1%
Of shares outstanding
67.7%
Held as options
-107
Holder change

Institutions report 511,876 shares against 414,274,017 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. Share count carried from an earlier filing (cy2026q1i).

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
JANE STREET GROUP, LLC$32.9Koptions only0.00%11qOPTIONS
SIMPLEX TRADING, LLC$30.0K76,5000.00%8qHELD
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.$22.0K400,0000.00%3qHELD
Axiom Investment Management LLC$1.4K25,3750.00%2qHELD
Heritage Investment Group, Inc.$53910,0000.00%newNEW
FLOW TRADERS U.S. LLC$121,5320.00%2qHELD
BARCLAYS PLC$010.00%newNEW

Five percent filings

Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →

FiledFormFiler % of class
2026-08-1413G/AArmistice Capital, LLCwith 1 co-filers9.4%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 20266$86.8K511,87630067.7%
Q1 2026113$26.7M105,363,0982526162.5%
Q4 2025103$27.1M62,016,9561423294.0%
Q3 2025107$41.2M58,709,7521436154.0%
Q2 2025110$39.6M70,807,4151325303.2%
Q1 2025115$36.7M51,052,8242028338.7%
Q4 2024122$67.0M61,163,6253331266.8%
Q3 202497$49.7M55,292,5411519313.7%
Q2 2024120$29.0M80,693,4382227410.3%
Q1 2024119$64.3M94,837,7222126430.4%
Q4 2023116$43.2M79,468,5272035380.3%
Q3 2023116$57.2M95,042,1411029380.3%
Q2 2023130$124.1M95,594,0321937400.1%
Q1 2023148$184.4M104,668,3031856340.1%
Q4 2022138$277.8M88,100,7521146400.6%
Q3 2022194$483.9M97,724,8883064381.0%
Q2 2022185$375.2M89,679,0891866451.1%
Q1 2022195$467.4M79,432,7152854511.2%
Q4 2021192$596.4M77,352,2551957562.7%
Q3 2021192$697.2M75,275,4861756602.6%
Q2 2021197$940.0M76,211,0451954703.0%
Q1 2021201$1.0B79,429,4271862693.0%
Q4 2020227$1.3B78,922,6523769675.8%
Q3 2020209$797.3M81,633,0612753683.1%
Q2 2020208$716.9M77,127,9853277483.6%
Q1 2020185$490.6M74,560,1442458463.0%
Q4 2019194$694.0M80,070,5462255553.4%
Q3 2019187$776.9M82,763,2602257393.5%
Q2 2019191$954.8M81,947,4933673397.4%
Q1 2019188$667.1M65,992,9411960535.5%
Q4 2018198$798.3M65,872,9922355.4%